Trials that use: Intention-to-treat analysis
New to this method? Read the tutorial →
10,079 results
- MAP4BUPIndependent statistical analysis of Mobile Medication Adherence Platform for Buprenorphine-Naloxone During Treatment of Opioid Use Disorder: Phase I Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAPP-IIIndependent statistical analysis of Developing a Positive Psychology Intervention to Promote Health Behaviors in Metabolic Syndrome: Proof-of Concept Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MAPSIndependent statistical analysis of MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01411345).
- Maraviroc as GVHD Prophylaxis in Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maraviroc as GVHD Prophylaxis in Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02167451).
- Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00948753).
- Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Complete Statistical AnalysisIndependent statistical analysis of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Marijuana in Combination With Opioids in Palliative and Hospice Patients: Complete Statistical AnalysisIndependent statistical analysis of Marijuana in Combination With Opioids in Palliative and Hospice Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03233633).
- MARRSIndependent statistical analysis of Millipede AspiRation for Revascularization in Stroke (MARRS) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05714501).
- MARSIndependent statistical analysis of Microvascular Flow Assessment Repeatability Study: The MARS Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01242020).
- MARSIndependent statistical analysis of Project MARS: Mobile-Assistance for Regulating Smoking: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04376489).
- Mars Flavanol Exercise and Cognitive Function Study: Complete Statistical AnalysisIndependent statistical analysis of Mars Flavanol Exercise and Cognitive Function Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01180127).
- MARS GIIndependent statistical analysis of Safety and Feasibility of the Use of the Dual Robotic Arm Accessory With the Levita Magnetic Surgical System in Laparoscopic Procedures: primary endpoint results, effect estimate with confidence…
- MASCIIndependent statistical analysis of Allogeneic SCT Of Pts With SCID And Other Primary Immunodeficiency Disorders: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASHIndependent statistical analysis of Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects: Complete Statistical AnalysisIndependent statistical analysis of Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]-MD1003 in Healthy Male Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Mass-balance Study of [14C]-APD421 in Healthy Volunteers: Complete Statistical AnalysisIndependent statistical analysis of Mass-balance Study of [14C]-APD421 in Healthy Volunteers: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02881840).
- Massive Iron Deposit Assessment: Complete Statistical AnalysisIndependent statistical analysis of Massive Iron Deposit Assessment: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01572922).
- Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: Complete Statistical AnalysisIndependent statistical analysis of Massive Pulmonary Embolism: Trial of Non-immunogenic Recombinant Staphylokinase VS Alteplase FORPE: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- MASTIndependent statistical analysis of MAST Trial: Multi-modal Analgesic Strategies in Trauma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03472469).
- MASTIndependent statistical analysis of Study of the Mechanisms of Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00595153).
- Mast Cell Activation Test in Allergic Disease: Complete Statistical AnalysisIndependent statistical analysis of Mast Cell Activation Test in Allergic Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03406325).
- Mastectomy Flap Temperature Study: Complete Statistical AnalysisIndependent statistical analysis of Mastectomy Flap Temperature Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05395936).
- MasterKey-01Independent statistical analysis of A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid Tumors.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MATCh-GDMIndependent statistical analysis of Metabolic Analysis for Treatment Choice in Gestational Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03029702).
- Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: Complete Statistical AnalysisIndependent statistical analysis of Maternal Metabolic and Molecular Changes Induced by Preconception Weight Loss and Their Effects on Birth Outcomes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- MATINEEAn independent statistical analysis of the phase 3 MATINEE trial of mepolizumab 100 mg versus placebo in COPD with frequent exacerbations and raised eosinophil levels, covering the negative binomial exacerbation-rate analysis, Cox…
- MATOCSSIndependent statistical analysis of Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Mature B-Cell Lymphoma And Leukemia Study III: Complete Statistical AnalysisIndependent statistical analysis of Mature B-Cell Lymphoma And Leukemia Study III: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01046825).
- MAVERICIndependent statistical analysis of Maraviroc Efficacy for Hepatitis C: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02881762).
- MAVISIndependent statistical analysis of Study of a Melanoma Vaccine in Stage IIb, IIc, and III Melanoma Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: Complete Statistical AnalysisIndependent statistical analysis of Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MAXIMIZAIndependent statistical analysis of Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza…
- Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Maximizing Analgesia to Reduce Pain in Knee Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03098563).
- MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: Complete Statistical AnalysisIndependent statistical analysis of MBCT Delivered Via Group Videoconferencing for ACS Patients With Elevated Depression Symptoms: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MBIIndependent statistical analysis of Mechanisms of Mindfulness-based Interventions: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03571386).
- MBMM+Independent statistical analysis of My Baby My Move A Community Wellness Intervention: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04294095).
- MBSRIndependent statistical analysis of Mindfulness-Based Stress Reduction for Adults With Low-Risk Chest Pain Associated With Anxiety: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MBTAIndependent statistical analysis of Develop and Validation of Measurement-Based Transition Assistance: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05384171).
- MCAPIndependent statistical analysis of HIV Prevention Toolkit for HIV-negative Male Couples: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02494817).
- McCAVEIndependent statistical analysis of A Study Comparing the Efficacy and Safety of Vanucizumab and FOLFOX With Bevacizumab and FOLFOX in Participants With Untreated Metastatic Colorectal Cancer: primary endpoint results, effect estimate with…
- MDB003Independent statistical analysis of Feasibility Study of a Modular Control to Range System in Type 1 Diabetes Mellitus: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- MDDIndependent statistical analysis of Transcranial Alternating Current Stimulation for Major Depressive Disorder: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02339285).
- MDMNIndependent statistical analysis of Modulating Default Mode Network Function: A Transcranial Direct Current Stimulation (TDCS) Pilot Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- MDs on Botox Utility (MOBILITY): Complete Statistical AnalysisIndependent statistical analysis of MDs on Botox Utility (MOBILITY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00535938).
- MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: Complete Statistical AnalysisIndependent statistical analysis of MDX-010 in Treating Patients With Stage IV Pancreatic Cancer That Cannot Be Removed By Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- MDX1106-01Independent statistical analysis of A Study of MDX-1106 in Patients With Selected Refractory or Relapsed Malignancies: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- MEASURE 1 extIndependent statistical analysis of Extension in AS: Sustainability of Benefits, Safety and Tolerability: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01863732).
- Measurement of Relaxin Peptide in Multiple Sclerosis (MS): Complete Statistical AnalysisIndependent statistical analysis of Measurement of Relaxin Peptide in Multiple Sclerosis (MS): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01909492).
- Measures of Gait Efficiency of Three Multi-Axial, Vertical Shock and Energy Storing-Return Prosthetic Feet During Simple & Complex Mobility Activities: Complete Statistical AnalysisIndependent statistical analysis of Measures of Gait Efficiency of Three Multi-Axial, Vertical Shock and Energy Storing-Return Prosthetic Feet During Simple & Complex Mobility Activities: primary endpoint results, effect estimate with confidence interval,…
- Measuring Brain Activity of School Age Children: Complete Statistical AnalysisIndependent statistical analysis of Measuring Brain Activity of School Age Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03407729).